• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

CoLucid Pharmaceuticals - Articles and news items


CoLucid Pharmaceuticals announces initiation of first Phase 3 pivotal trial of lasmiditan in migraine

Industry news / 30 April 2015 / Victoria White

CoLucid Pharmaceuticals has announced that the first patient has been randomised in its SAMURAI study, the Company’s Phase 3 pivotal trial of lasmiditan…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +